Pulmonary Arterial Hypertension Panel
New York
Approved
Genes
Conditions
- Pulmonary Arterial Hypertension (PAH)
Clinical Utility
- Confirmation of a clinical diagnosis in symptomatic individuals
- Identification of individuals at risk for developing the disease
- Recurrence risk assessment
Lab Method
- Deletion/Duplication Analysis
- Next-Gen Sequencing
Test Code
696
CPT Codes*
81405x2, 81406x2
ABN Required
No
Turnaround Time**
4 weeks
Preferred Specimen
Alternative Specimen
*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
**Reporting times are typical and begin once the sample(s) are received at the GeneDx laboratory, but could be extended in situations outside GeneDx’s reasonable control.
Test Documents
Billing
Targeted Variant Testing